Expertise in
29
conditions

Dr. Martin D. Mccarter

General Surgery
University Of Colorado Hospital Authority
1635 Aurora Ct, 
Aurora, CO 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
29
conditions
University Of Colorado Hospital Authority
1635 Aurora Ct, 
Aurora, CO 

Overview

Martin Mccarter is a General Surgeon practicing medicine in Aurora, Colorado.

Dr. Mccarter is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Melanoma, Gastrointestinal Stromal Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 193 peer reviewed articles and participating in 5 clinical trials. Dr. Mccarter is currently accepting new patients.

Specialties

General Surgery

Licenses

Surgery in CO

Hospital Affiliations

University Of Colorado Hospital Authority
Medical Center Of The Rockies

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

University of Colorado Hospital Authority
1635 Aurora Ct, Aurora, CO 80045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Efficacy and Safety of the CG-100 Intraluminal Bypass Device in Colorectal and Coloanal Anastomoses: Prospective, Open Label, Randomized Trial
Efficacy and Safety of the CG-100 Intraluminal Bypass Device in Colorectal and Coloanal Anastomoses: Prospective, Open Label, Randomized Trial
Enrollment Status: Recruiting
Publish Date: July 06, 2026
Intervention Type: Device, Procedure
Study Phase: Not Applicable
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
Study Phase: Phase 3
Pembrolizumab and All-Trans Retinoic Acid in Combination Treatment of Advanced Melanoma
Pembrolizumab and All-Trans Retinoic Acid in Combination Treatment of Advanced Melanoma
Enrollment Status: Completed
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Pembrolizumab with All-Trans Retinoic Acid
Study Phase: Phase 1/Phase 2
Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drugs: VESANOID, Ipilimumab
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large- and Small-Bowel Resection
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large- and Small-Bowel Resection
Enrollment Status: Completed
Publish Date: June 23, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

193 Total Publications

The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology.
The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology.
Journal: Research square
Published: June 12, 2026
Similar Doctors
Expertise in
19
conditions
Dr. Richard D. Schulick
General Surgery
Expertise in
19
conditions
Dr. Richard D. Schulick
General Surgery
Referral may be required

University Of Colorado Hospital

12605 E 16th Ave, 
Aurora, CO 
 (0.2 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Richard Schulick is a General Surgeon practicing medicine in Aurora, Colorado. Dr. Schulick is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Schulick is currently accepting new patients.

Expertise in
12
conditions
Dr. Thomas B. Reece
General Surgery
Expertise in
12
conditions
Dr. Thomas B. Reece
General Surgery
Referral may be required

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (0.1 miles away)
303-724-2809
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas Reece is a General Surgeon practicing medicine in Aurora, Colorado. Dr. Reece is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Aortic Dissection, Thoracic Aortic Aneurysm, Cystic Medial Necrosis of Aorta, Heart Valve Repair, and Aneurysm Repair. Dr. Reece is currently accepting new patients.

Expertise in
10
conditions
Dr. Trevor L. Nydam
General Surgery
Expertise in
10
conditions
Dr. Trevor L. Nydam
General Surgery
Referral may be required
Before you request

University Of Colorado Hospital

1635 Aurora Court, Suite C318, 
Aurora, CO 
 (0.1 miles away)
720-848-0833
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Trevor Nydam is a General Surgeon practicing medicine in Aurora, Colorado. Dr. Nydam is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Nutcracker Syndrome (NCS), Necrosis, Liver Failure, Liver Transplant, and Kidney Transplant. Dr. Nydam is board certified in American Board Of Surgery. Dr. Nydam is currently accepting new patients.

Frequently Asked Questions about Dr. Martin D. Mccarter

How do I make an appointment with Dr. Martin D. Mccarter?

You can book an appointment with Dr. Martin D. Mccarter by calling their office at 720-848-2700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Martin D. Mccarter a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Martin D. Mccarter is classified as an Elite expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Martin D. Mccarter specialize in?

While Dr. Martin D. Mccarter is a General Surgery, they have specific expertise in Melanoma, Gastrointestinal Stromal Tumor, and Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.

Does Dr. Martin D. Mccarter participate in research or clinical trials?

Yes. Dr. Martin D. Mccarter has published 193 articles and abstracts on conditions like Melanoma. You can view a list of Dr. Martin D. Mccarter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Martin D. Mccarter accept my insurance?

Dr. Martin D. Mccarter accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 720-848-2700 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccarter's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 20 Advanced Conditions
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile